|
Volumn 148, Issue 6, 2008, Pages 484-
|
D-dimer testing in pregnancy: Clinically useful, but at what cost?
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
COST BENEFIT ANALYSIS;
DEEP VEIN THROMBOSIS;
HEALTH CARE POLICY;
HEALTH CARE SYSTEM;
LETTER;
PREGNANCY;
PRIORITY JOURNAL;
FEMALE;
HEMAGGLUTINATION TEST;
HUMAN;
NOTE;
PREGNANCY COMPLICATION;
STATISTICAL ANALYSIS;
VEIN THROMBOSIS;
FIBRIN DEGRADATION PRODUCT;
FIBRIN FRAGMENT D;
UNCLASSIFIED DRUG;
DATA INTERPRETATION, STATISTICAL;
FEMALE;
FIBRIN FIBRINOGEN DEGRADATION PRODUCTS;
HEMAGGLUTINATION TESTS;
HUMANS;
PREGNANCY;
PREGNANCY COMPLICATIONS, HEMATOLOGIC;
VENOUS THROMBOSIS;
|
EID: 41149121587
PISSN: 00034819
EISSN: None
Source Type: Journal
DOI: 10.7326/0003-4819-148-6-200803180-00020 Document Type: Letter |
Times cited : (9)
|
References (3)
|